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Abstract 
Background: This study aimed to the serological and molecular diagnosis of Toxoplasma 
gondii infections and related risk factors in patients with thalassemia major and healthy con-
trols.  
Methods: This case-control study was performed in Shahrekord University of Medical 
Sciences, Shahrekord, west of Iran from Jan 2014 to Jan 2015. Overall, 235 patients with 
thalassemia major and 235 healthy controls were enrolled. Assessment of anti-Toxoplasma 
antibodies in sera samples was performed using commercial ELISA kits. In order to the 
molecular investigate of T. gondii in blood samples, a relatively new molecular assay, LAMP 
technique based on Toxoplasma SAG1 gene was conducted for the first time. The specificity 
of LAMP outer primers for the T. gondii detection was confirmed by sequencing the puri-
fied PCR product.  
Results: 51.9% of thalassemia patients and 34.8% of healthy controls were positive for 
anti-Toxoplasma IgG antibodies, which the difference was statistically significant (P<0.01). 
In terms of anti-Toxoplasma IgM antibody, 3.4% of thalassemia patients and 2.1% of healthy 
individuals were positive, which the difference was not statistically significant (P=1). Based 
on SAG1-LAMP, 9.78% of the thalassemia patients and 5.95% of healthy controls were 
positive for T. gondii DNA, which the difference was not statistically significant (P≤0.230).  
Conclusion: Thalassemia patients, probably due to repeated blood transfusion and conse-
quently, immune deficiency, are at risk of transmitting Toxoplasma infection more than 
healthy people. Therefore, screening of Toxoplasma infection in blood transfusion centers 
may be effective in the prevention of toxoplasmosis in these patients. 
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Introduction 
 
oxoplasmosis is one of the most 
common parasitic infections of hu-
man and animals caused by a 
protozoan of the Apicomplexa phylum, called 
Toxoplasma gondii (T. gondii). This parasite has a 
considerable dispersion throughout the world 
(1, 2). As an opportunistic parasite, T. gondii 
can be transmitted through blood transfusion 
and can be dangerous in immune-
compromised people and pregnant women (2, 
3). In people with an impaired immune system, 
patients with various malignancies and colla-
gen vascular disease, reactivation of parasites 
can cause widespread inflammation and sys-
temic involvement of many organs, especially 
the central nervous system, heart, and lungs 
(3). As a result of severe infection and wide-
spread inflammation in the mentioned organs, 
encephalomyelitis, myocarditis, and pneumo-
nia can occur and consequently in the absence 
of definitive early diagnosis and effective 
treatment can lead to death (2-4). In patients 
at risk, the accurate and timely diagnosis of 
disease is very helpful in controlling and treat-
ing the disease. Serological, biological, histo-
logical, and molecular methods or some com-
bination of these assays are used to diagnosis 
the infection in humans (3, 5).  
Thalassemia, also called Mediterranean ane-
mia, is a form of inherited autosomal recessive 
blood disorder characterized by abnormal 
formation of hemoglobin (5). Immune status 
in patients with thalassemia has been investi-
gated by studying cellular and humoral im-
mune system (6). Due to a basic defect in the 
host defense, thalassemia has an increased risk 
for serious opportunistic infections such as 
toxoplasmosis and this may be associated with 
the chronic immune stimulation by repeated 
blood transfusions, iron overload, splenecto-
my and immune deficiency (7, 8). Precise early 
detection and consequently, effective treat-
ment of toxoplasmosis as a dangerous oppor-
tunistic infection in thalassemia patients, is 
very useful in controlling and treating the dis-
ease. 
Loop-mediated isothermal amplification 
(LAMP) technique, a relatively new DNA am-
plification technique, is an isothermal nucleic 
acid amplification technique which due to its 
simplicity, ruggedness, high sensitivity and 
specificity and low cost could provide major 
advantages (9, 10). This method can amplify a 
few copies of targeted DNA to 109 in less 
than an hour (4, 10). The LAMP has already 
been successfully used for rapid detection of 
human infectious agents such as viruses, bac-
teria, parasites, and fungi (11).  
The aim of the present study was to primary 
serologic screening and then sensitive and spe-
cific molecular detection of T. gondii infection 
using a SAG1-LAMP technique in patients 
with thalassemia major and healthy controls. 
 
Methods  
 
Design, subjects, settings, and inclusion 
This case-control study was performed in 
Shahrekord University of Medical Sciences, 
Shahrekord, west of Iran from Jan 2014 to Jan 
2015. The study population consisted of 235 
thalassemia major patients referred to Thalas-
semia Clinic of Hajar Hospital, Shahrekord, 
Iran as the case group and 235 healthy sub-
jects in the same age and sex distribution as 
the control group. Infection of patients with 
thalassemia major was confirmed according to 
the patient's history, medical records, blood 
tests and hemoglobin electrophoresis. In the 
control group, healthy individuals referred to 
healthcare centers in Shahrekord for the an-
nual checkup were also selected after inform-
ing them about the aims of the study. Demo-
graphic/clinical data and informed written 
consent were obtained from all of the partici-
pants. Clinical and laboratory evaluation of 
controls was performed in the same way as for 
the cases.  
 
T 
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Identification of anti-Toxoplasma specific 
antibodies 
After collecting 5 ml of whole blood sam-
ples from all participants, the samples were 
transferred to a Medical Research Laboratory 
in Parasitology Department of Shahrekord 
University with respect to cold chain condi-
tions. All hyperlipidemic or hemolysis sera 
were excluded or replaced with suitable alter-
native samples. After separation of serum by 
centrifugation, the sera samples were kept at -
20 °C until examination. To search for specific 
anti-Toxoplasma IgM and IgG antibodies in the 
serum samples, the ELISA kits (Toxoplasma 
IgG/IgM ELISA kit, ACON Laboratories, 
Inc., USA) which have sensitivity and specific-
ity of more than 95% were used. The experi-
mental procedures were carried out according 
to the kit manufacturer's protocol. Finally, ab-
sorbance was measured by an ELISA reader 
(Stat Fax 2100/ UK) at 450 nm. 
 
Buffy coat isolation and DNA extraction  
In order to the optimal purification of buffy 
coat layer from blood samples, the white 
blood cells (WBCs) isolating solution was used 
(9). The DNA was extracted from buffy coat 
specimens and the mouse harvested T. gondii 
tachyzoites using the DNG-plus kit (Sina gene 
Co., Iran) based on the kit protocol. The light 
absorption was measured at a wavelength of 
260/280 nm using NanoDrop spectropho-
tometer (ND-2000, Thermo Scientific/ USA). 
 
LAMP reaction  
In order to carry out the LAMP on extracted 
DNA from blood samples of thalassemia ma-
jor patients and healthy control group, the 
primers presented for the SAG1 gene of T. 
gondii (GenBank accession no. X14080) were 
used (2). The reaction mixture was used in a 
final volume of 25 µl, containing 1.4 mM 
dNTP, 0.8 M betaine, 8 U Bst DNA polymer-
ase (New England Biolabs), 1X Buffer en-
zyme [Tris-HCL (20 mM), KCL (10 mM), 
MgSO4 (9 mM), (NH4)2SO4 (10 mM)], 5 pmol 
each of F3 and B3 primers, 40 pmol each of 
FIP and BIP primers, 6.5 μl DDW water, 1 μl 
of template DNA and 8 mM MgSO4. The 
content of the microtubes was thoroughly 
mixed by quick spin and put into the thermal 
cycler for DNA amplification at 65 °C for 60 
min. In addition to the thermal cycler, water 
bath, and heater blocks were also used for 
DNA amplification. After completion of the 
LAMP reaction, 1 µl of 0.1% SYBR Green I 
was added to each tube and then the tubes 
were assessed under natural and UV light with 
a wavelength of 312 nm. Positive tubes were 
green while the negative tubes remained to 
pale orange color.  
 
Statistical analysis 
Statistical analyses were performed using 
SPSS statistical software (version 20.0; Chica-
go, IL, U.S.A). All data were presented as the 
mean ± SD. To compare qualitative and quan-
titative variables, Chi-square and independent 
sample T-tests were used respectively. P-
values less than 0.05 were considered statisti-
cally significant and 95% confidence intervals 
were reported. 
 
Ethical approval 
The study protocol conforms to the ethical 
guidelines of the 1975 Declaration of Helsinki 
as reflected in a priori approval by the institu-
tion’s Ethics in Research Committee (Ref. No. 
200/13/2015). 
 
Results 
 
Sociodemographic characteristics of par-
ticipants  
Overall, 470 participants (235 patients with 
thalassemia major and 235 healthy control 
subjects) participated in this study. The age 
range of thalassemia major patients was 10-80 
yr with a mean age 48.6±16.58 yr and in the 
control group ranged from 10-78 yr with an 
average age of 48.1±16.81 yr. T-test showed 
no difference in the age of the two groups 
(P=0.95). Regarding gender, the thalassemia 
patients included 106 men (45.1%) and 129 
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women (54.8%) and the control group con-
sisted of 109 males (46.3%) and 126 women 
(53.6%), which chi-square test showed no dif-
ference in terms of gender in the two groups 
(P=0.851).  
 
Seroprevalence of anti-Toxoplasma IgM 
and IgG antibodies 
Out of 235 patients with thalassemia major, 
122 patients (51.9%) were positive for anti-
Toxoplasma IgG antibodies as well as 82 of 235 
healthy individuals (34.8%) were positive for 
this antibody, therefore a significant difference 
was observed between the two groups 
(P<0.01). Regarding anti-Toxoplasma IgM anti-
bodies, 3.4% of patients with thalassemia and 
2.1% of healthy individuals were positive for 
this antibody (Table 1), therefore a statistically 
significant difference was not observed be-
tween the two groups (P=1).  
 
Table 1: Demographic characteristics of thalassemia patients and healthy control group according to the T. 
gondii seropositivity 
 
 
Variable 
 
Status 
 
T† 
P-value C‡ 
Positive N (%) 
P-value 
Positive N (%) 
Age(yr) 10-19 23 (46.2)  
0.001 
16 (65.2)  
 
0.001 
 
20-29 16 (27.8) 6 (38.7) 
30-39 18 (37.5) 8 (19.1) 
40-49 11 (36.9) 18 (25.7) 
50-59 19(31.2) 13 (13.6) 
>60 35 (52.6) 21 (65.3) 
 Total 122 (51.9) 82 (34.8) 
Sex Male 43 (40.5)  
0.001 
39 (35.7) 0.001 
Female 79 (61.2) 43 (34.1) 
 Total 122 (51.9) 82 (34.8) 
Place of residence Urban 63 (63.6) 0.871 71 (53.2) 0.754 
Rural 59 (56.4) 11 (45.2) 
 Total 122 (51.9) 82 (34.8) 
Contact with cat Touch 74 (61.3)  
0.001 
56 (36.7)  
0.693 Non-touch 48 (52.8) 26 (41.5) 
 Total 122 (51.9) 82(34.8) 
 
Education 
 
Illiterate 38 (57.3) 0.584 25 (59.2) 0.974 
Elementary 26 (47.1) 19 (32.1) 
Guidance 17 (39.6) 25 (47.3) 
High School 23 (46.2) 8 (24.1) 
University 18 (28.9) 5 (31.1) 
 Total 122 (51.9) 82 (34.8) 
Job Housekeeper 27 (46.5) 0.002 33 (52.4)  
0.241 
 
Employee 17 (29.8) 15 (13.9) 
Farmer 25 (36.7) 12 (19.4) 
Rancher 53 (61.9) 22 (33.5) 
 Total 122 (51.9) 82 (34.8) 
Meat diet Red meat 65 (47.2) 0.746 48 (56.2) 0.344 
White meat 57 (32.4) 34 (26.4) 
Total 122 (51.9) 82 (34.8) 
Vegetable diet Continuous 59 (37.4) 0.364 43 (48.2) 0.714 
Periodic 63 (42.1) 39 (26.5) 
Total 122 (51.9) 82 (34.8) 
Meat cooking status Cooked 41 (38.7) 0.001 29 (32.8) 0.124 
Undercooked 81 (64.3) 53 (41.5) 
Total 122 (51.9) 82 (34.8) 
†Thalassemia patients, ‡Control group 
 
Iran J Parasitol: Vol. 14, No. 1, Jan-Mar 2019, pp.20-28 
 
24                                                                                                  Available at: http://ijpa.tums.ac.ir                                                                                                     
There is a statistically significant difference 
regarding the serum prevalence of Toxoplasma-
specific IgG antibodies for age and sex varia-
bles in each group, as well as, the differences 
were also significant regarding contact with 
cats, job, and consumption of meat. Therefore, 
in terms of age, the highest prevalence was 
seen in the age group of 10-19 yr and above 
60 yr and the prevalence was increased with 
age (P=0.001). With regard to gender, the 
prevalence was higher in men than women 
and a significant difference was also observed 
in both groups (P=0.001). The prevalence was 
higher in people who had contact with cats 
than the people who had no close contact 
with cats (P). Moreover, regarding the job var-
iable, the prevalence of Toxoplasma infection 
was higher in housewives and butchers 
(P=0.002). The prevalence of Toxoplasma in-
fection was also higher in people who con-
sumed undercooked meat than those who 
consumed fully cooked meat (P=0.001) (Table 
1). Results of the logistic regression model 
showed that in the presence of all the variables, 
age and sex are the most important factors in 
the prevalence of Toxoplasma infection in pa-
tients with thalassemia major (P=0.001). Ac-
cording to the odds ratio values and other var-
iables values remaining constant in the statisti-
cal model, by addition of 1 year to the age, the 
risk of infection is 1.051 times greater. More-
over, considering the significance of gender, 
the chance of getting infected by Toxoplasma in 
women rises 1.011 times.  
 
LAMP reaction 
Results of LAMP technique based on SAG1 
gene of Toxoplasma showed that 23 samples 
(9.78%) in the major thalassemia patients 
group (Figs. 1 and 2) and 14 samples (5.95%) 
in the control group were positive for T. gondii 
DNA. This means that of 105 IgM-/IgG-, 8 
IgM+/IgG+ and 122 IgM-/IgG+ samples in 
the case group, 5, 8 and 10 samples were posi-
tive using the SAG1-LAMP technique, respec-
tively. Moreover, out of 148 IgM-/IgG-, 5 
IgM+/IgG+ and 82 IgM-/IgG+ samples in 
the control group, 3, 5 and 6 samples were 
positive by SAG1-LAMP technique, respec-
tively (Table 2). 
 
 
 
Fig. 1: Analysis results of SAG1-LAMP on blood 
samples from thalassemia patients using SYBR Green 
I DNA stain under UV light. C-, negative control; 
C+, positive control; tubes 1–6, randomly selected 
samples from patients 
 
 
 
Fig. 2: Analysis results of SAG1-LAMP of blood 
samples from thalassemia patients on 1.5% agarose 
gel stained with SYBR Safe DNA gel stain. L, 100 bp 
molecular weight marker; C-, negative control; C+, 
positive control; lanes 1–6, randomly selected sam-
ples from patients 
 
 
Based on the results of SAG1-LAMP, there 
was not a statistically significant difference in 
terms of age and sex in both groups so that 
the prevalence of Toxoplasma infection was 
higher in people over 60 yr and in women. As 
well as, for other parameters such as contact 
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with cats, job, consumption of raw or under-
cooked meat, place of residence, the level of 
education and vegetable consumption, there 
was no statistically significant difference. 
 
Table 2: The results of SAG1-LAMP based on serologic status of thalassemia patients and healthy control 
group for T. gondii 
 
Studied 
groups 
 
 
T 
N (%) 
C 
N (%) 
Total 
N (%) 
 
P-value 
 
 
 
 
ELISA 
 
N (%) 
 
IgG- / IgM- 
 
 
105 (44.68) 
 
 
148 (62.97) 
 
253 (53.82) 
 
> 0.05 
 
IgG+ / IgM+ 
 
 
8 (3.40) 
 
 
5 (2.12) 
 
 
13 (2.76) 
 
1 
 
IgG+ / IgM- 
 
 
122 (51.91) 
 
 
82 (34.89) 
 
 
204 (43.40) 
 
<0.01 
 
Total  
  
235 (100) 
 
235 (100) 
 
470 (100) 
 
 
 
 
SAG1-LAMP 
 
Positive N (%) 
 
IgG- / IgM- 
 
 
5 (2.12) 
 
3 (1.27) 
 
8 (1.70) 
 
 
 
 
<0.23 
 
IgG+ / IgM+ 
 
 
8 (3.40) 
 
5 (2.12) 
 
13 (2.76) 
 
IgG+ / IgM- 
 
 
10 (4.25) 
 
6 (2.55) 
 
16 (3.40) 
 
Total  
  
23 (9.78) 
 
14 (5.95) 
 
37 (7.87) 
 
 
Discussion  
 
For a long time, toxoplasmosis has been 
known as an opportunistic infection in the 
immunocompromised patients. It is also 
known as the third leading cause of death in 
AIDS patients after Pneumocystis and Cryptospor-
idium, which makes it an important issue (12-
14). In this study, 55.31% of patients with tha-
lassemia major and 37.02% of healthy individ-
uals were positive for anti-Toxoplasma antibod-
ies. The higher anti-Toxoplasma IgM and IgG 
antibodies titers in patients with thalassemia 
major compared with the control group may 
be due to that Thalassemic patients are more 
likely to be at risk for Toxoplasma infection 
than healthy individuals due to repeated blood 
transfusions. The results of this study were in 
contradiction with those in patients with tha-
lassemia major (15) 19.4%, in neoplasia pa-
tients 63% (16), in patients with epilepsy 
67.1% (17) and in hemodialysis patients 80% 
(18). On the other hand, the results were in 
line with those in cancer patients 45.2% (19) 
and in diabetic patients 52.6% (20). In this 
study, the titer of anti-Toxoplasma IgM anti-
body in patients with thalassemia major 
(3.4%), was almost compatible with the results 
of study in immunodeficiency and hemodialy-
sis patients 2.3%, (21) and contradicted in ne-
oplasia patients 6.5% (16), in cancer patients 
10.3% (19), in blood donors 0.28% (22), and 
with those of (23) in kidney disease patients, 
6.7%. Up to now, the reason for the differ-
ences in the results are not fully understood, 
but various factors such as environmental 
conditions, cultural habits, foods, and safety 
level of the people against this parasite, are the 
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factors that can effect on the level of infection 
(12). 
The prevalence of Toxoplasma infection in-
creases with age so that in the fourth decade 
of life, the prevalence of infection reaches 
90% (24). The results of present study showed 
a statistically significant difference in terms of 
the variable of age in both groups (P<0.05). 
These results conflict with some studies 
around the world (25, 26); but it was in line 
with another study (19, 20, 27). In this re-
search, regarding gender, a significant differ-
ence was seen in both groups, that the preva-
lence of IgG antibodies was higher in women. 
Maybe because women are more susceptible 
to infection with T. gondii (while cleaning meat 
and vegetables at home) than men. This result 
is incompatible with the results of studies (18, 
27) and in line with the results of (19,21,26) 
studies. Occupation and its association with 
prevalence of Toxoplasma infection have been 
addressed in some studies (28-31). In the pre-
sent study, a statistically significant difference 
was seen in the case (patients with thalassemia 
major) and control (healthy individuals) group, 
so, the prevalence of Toxoplasma infection was 
higher in cases who were working at a slaugh-
terhouse or as butchers (P<0.05). These peo-
ple may have been more at risk for this infec-
tion because of their contact with fresh meat. 
In present research the seroprevalence of IgG 
antibodies in both groups was higher in indi-
viduals that had contact with cats than those 
who did not have any close contact with this 
animal and this difference was significant for 
both groups (P<0.05). The prevalence of tox-
oplasmosis is higher in people who work in 
slaughterhouses and with low literacy level 
than the others (32-36). People who are less 
educated are more exposed to this infection 
due to the lack of awareness regarding the 
ways of transmission and lack of personal hy-
giene. In the present study, the highest inci-
dence of infection in both groups was for 
those who ate undercooked meat, and a statis-
tically significant difference was observed for 
the case group. 
Regarding the results of SAG1-LAMP tech-
nique, the prevalence of T. gondii infection in 
people over 60 yr and in women was higher 
than the others that this is probably due to a 
higher exposure to parasite, direct contact 
with cat and/or consumption of contaminated 
meat by tissue cyst, that there was no statisti-
cally significant difference (P>0.05). Since the 
Toxoplasma DNA was found using SAG1-
LAMP in blood samples from 5 patients with 
thalassemia major and 3 subjects in the con-
trol group who’s their serology test result was 
negative, it is likely that in these people the 
Toxoplasma infection occurred recently and 
sampling was done before increasing the se-
rum antibody titer. In this study, T. gondii 
DNA was found in blood samples from 10 
patients with thalassemia major and 6 people 
in the control group who’s their serum test 
results were negative for the presence of IgM 
antibody, but positive for IgG antibodies. 
Since immune deficiency can cause reactiva-
tion of chronic and latent Toxoplasma infec-
tions, the existence of parasite DNA in blood 
samples may prove that the infection recently 
converted from chronic to acute but the IgM 
antibody titers are not to the extent that is de-
tectable in the serum, yet. In addition, SAG1-
LAMP technique on blood samples from 8 
patients with thalassemia major and 5 subjects 
in the control group who had the IgG and 
IgM antibodies in their serum, approved the 
existence of the parasite's DNA. Although, 
this finding may indicate the presence of acute 
Toxoplasma infection in individuals, but to 
prove this diagnosis it is needed to perform 
additional supplementary tests such as inocu-
lation of the patient's blood to sensitive ani-
mals or to cell cultures such as MRC5 or Vero 
cell lines as well as conducting complementary 
serum tests like IgG avidity (1,12). Since the 
sensitivity and specificity of diagnostic LAMP 
technique are much higher than the conven-
tional molecular diagnostic methods such as 
PCR or common serology tests, it can be used 
to identify acute toxoplasmosis in humans and 
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especially in immunocompromised people, 
including thalassemia major patients.  
 
Conclusion 
 
Thalassemia patients are more likely to be at 
risk for Toxoplasma infection than healthy indi-
viduals due to repeated blood transfusions. 
Therefore, screening blood for Toxoplasma in-
fection in blood transfusion centers may be 
effective in preventing toxoplasmosis in these 
patients. 
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